Cancer is the second leading cause of death globally, trailing only heart disease. In the
United States alone, 1.9 million new cancer cases and 609,360 deaths were recorded for …

Moving a new drug from bench to bedside is a long and arduous process. The tactic of drug
repurposing, which solves “new” diseases with “old” existing drugs, is more efficient and …

Endometrial cancer (EC) is the 6th most common cancer in women around the world. Alone
in the United States (US), 66,200 new cases and 13,030 deaths are expected to occur in …

Drug discovery is usually a rule-based process that is carefully carried out by pharmacists.
However, a new trend is emerging in research and practice where artificial intelligence is …

Introduction: Exploring the potential efficacy of a drug is a valid approach for drug
development with shorter development times and lower costs. Recently, several …

Breast cancer (BC) is a heterogeneous and complex disease characterized by different
subtypes with distinct morphologies and clinical implications and for which new and effective …

The prevalence of cancer in 2022, according to World Health Organization (WHO) data, is
20 million new cases and 9.7 deaths. The comparison of death rates based on gender is that …

Background Prioritizing candidate drugs based on genome-wide expression data is an
emerging approach in systems pharmacology due to its holistic perspective for preclinical …

Computational drug repurposing aims to discover new treatment regimens by analyzing
approved drugs on the market. This study proposes previously approved compounds that …

Cancer is a highly debilitating disease affecting millions around the world. The current drugs
marketed are incapable of eradicating the same. Hence, there is a dire need to find a new …